Our team

HEAD OF REGULATORY STRATEGY AND DRUG DEVELOPMENT CLINICIAN

Kirsty is a clinician and expert medical assessor with extensive experience of regulation in clinical trials and more than a decade’s experience at the MHRA.

SENIOR DRUG DEVELOPMENT CLINICIAN

Dominique is a physician scientist and university professor with extensive hands-on experience of strategic drug hunting and drug development in pharma and academia.

HEAD OF CLINICAL OPERATIONS

Geoff has worked at a senior level on trials Phases I to IV on a variety of international projects involving therapeutic agents ranging from small molecules to gene therapy, and is highly regarded for his success in leading R&D teams.

SENIOR DRUG DEVELOPMENT CLINICIAN

Arash is a clinician scientist with broad experience in drug development, including target discovery, early phase clinical trial design, Mendelian/rare disorders, oligonucleotide therapeutics, CV, oncology, drug repositioning and novel platform/precision medicine approaches.

SENIOR DRUG DEVELOPMENT CLINICIAN

Raj is a company creation executive and commercial and technical due diligence professional who brings extensive experience of asset and unmet need analyses, competitor therapy area pipeline investigations, and indication selection therapeutic area mapping.

SENIOR DRUG DEVELOPMENT CLINICAL SCIENTIST

Aaron is a senior specialist who has brought to market several compounds and brings extensive experience in the management of development programs, strategic alliances, coordinating global business initiatives and portfolio management.

SENIOR DRUG DEVELOPMENT CLINICAL SCIENTIST

Claire is a drug development professional who brings more than 20 years’ experience of clinical research programmes across all phases and brings substantial experience in immunology and late-stage global regulatory filings.

STRATEGIC ADVISOR

Koki is an is an experienced commercial executive and pharmaceutical physician with a track record of leading and managing business units as S/VP, supervising sales, marketing, and product communication in addition to launching new products and evaluating in-licensing opportunities.

DRUG DEVELOPMENT CLINICIAN

Christine is an expert in cancer drug development and seasoned pharmaceutical physician with an extensive track record in integrated clinical development across all stages of the product life cycle and the business.

EARLY DRUG DEVELOPMENT SCIENTIST

Tim is an experienced chief scientific officer with a track record of delivering on small molecule, biologics, and new chemical (NCE) project as well as successful biotech deals and partnerships.

DRUG DEVELOPMENT CLINICIAN

Alex is an academic NHS clinician and NIHR fellow working at the intersection of academia, medicine and industry specialising in oncology, translational medicine, integrative immunogenomics and data science.

EARLY DRUG DEVELOPMENT SCIENTIST

Sara is a pharmaceutical scientist and translational biology specialist with more than 35 years of experience in immunology, immunoinflammation and oncology.

DRUG DEVELOPMENT CLINICIAN

Stephen is a clinician, medical affairs and clinical development professional with extensive translational experience and track record in conducting phases I-IV trials.

DRUG DEVELOPMENT CLINICIAN

Matthew is an acute medicine consultant, clinician scientist and principal investigator on several multi-centre trials focused on cardiovascular, metabolism, and pulmonary diseases, and Covid-19.

DRUG DEVELOPMENT CLINICIAN

Harriet is a paediatrician with expertise primarily in oncology. Her PhD investigated cancer drivers and synthetic lethality in osteosarcoma. She founded and chairs PCD Research, a medical research charity.

DRUG DEVELOPMENT CLINICIAN

Dimitrios is an award winning clinical-academic with a focus on skin cancer epidemiology and the use of artificial intelligence in skin cancer prevention and diagnosis. Published across a range of scientific disciplines. Author of medical and fiction books. Dermatology trainee (resident) supported by a prestigious NIHR Academic Clinical Fellowship.

DRUG DEVELOPMENT CLINICIAN

Ian is a cardiology and electrophysiology consultant with extensive knowledge of pacing, cardiac electrophysiology, atrial fibrillation, and heart failure; and experience in medical devices and diagnostics, including limited and commercial pre-clinical release.

DRUG DEVELOPMENT CLINICIAN

Bhavik is a consultant General and Interventional Cardiologist with 13 years’ experience of working in the NHS and a PhD in cardiovascular physiology. He brings extensive experience in leading regional/national academic and clinical teams, and a track-record of running clinical trials.

DRUG DEVELOPMENT CLINICIAN

Matthew is a prizewinning neuroscientist and doctor with a decade of research experience in functional neuroimaging, computational cognitive neuroscience, and neuropsychopharmacology.

DRUG DEVELOPMENT STATISTICIAN

Hakim is a specialist in the design and analysis of clinical trials, providing critical input to creation, design and delivery of pioneering drug development programmes across all clinical trial phases, therapeutic and disease areas.

STRATEGY DIRECTOR

Sneha is a health tech professional with more than 12 years’ experience of scaling tech-enabled approaches in healthcare across a range of platforms including AI, corporate strategy, and commercialisation in drug development.

STRATEGY CONSULTANT

Freddie is UCL and Francis Crick oncology PhD and former grants adviser in infection and immunobiology at the Wellcome Trust working across clinical development, strategy and business development.

STRATEGY DIRECTOR

Strategy and business development executive, Steven has led multiple therapeutic landscape assessments across clinical and commercial stage assets, using the inputs to support business development and support R&D strategy.

CLINICAL OPERATIONS PROJECT MANAGER

Eulene is a clinical research professional with more than thirty years’ experience of clinical operations, and fifteen years managing Phase I-IV clinical trials Worldwide and Europe in particular.

CLINICAL PROJECT MANAGER

Victoria is a clinical research professional and brings a considerable track record in patient recruitment, trial feasibility, study setup and clinical trial management.

CLINICAL OPERATIONS DIRECTOR

Shirish has more than 28 years’ experience working across Advanced Therapy Medicinal Products and brings a significant track record of setting up and conducting national, EU, and global clinical trials.

CLINICAL OPERATIONS PROJECT MANAGER

Jeremy has over 20 years’ experience in pharma and brings an impressive record in planning, setting up, coordinating, managing and overseeing every aspect of early phase clinical trials both nationally and globally.

CLINICAL OPERATIONS DIRECTOR

Harj has a significant track record of designing, managing and leading international and multi-centre studies through all phases; setting up clinical development teams; developing study protocols; and devising clinical development plans and study timelines.

CLINICAL OPERATIONS PROJECT MANAGER

Lisa is a study manager and early product development professional with more than 10 years’ industry experience of setting up and managing Phase I, II, III and IV studies across multiple sites in the UK and EU across a broad range of therapeutic areas.

GRADUATE PROJECT MANAGER

Zuhair was a BBSRC scholar at UCL’s Drug Discovery Lab, where he recently completed his PhD. He specialises in computational, biophysical and cell biology methods in immune-oncology and brings expertise in experimental pharmacology and genetic, cellular and molecular biology.

DRUG DEVELOPMENT ANALYST

Pharmacology graduate knowledgeable in bioinformatics approaches, Katie has researched in multiple therapeutic areas including neuroscience, cardiovascular, and inflammation, and has previous operational experience working in a biomanufacturing and medical diagnostics company.

DRUG DEVELOPMENT ANALYST

Maxim is an award winning biochemical engineering graduate skilled in bioprocess modelling and pharmaceutical product analyses, with particular interests in regenerative medicine products, cell and gene therapy, and AAV. 

INFORMATION GOVERNANCE CONSULTANT

Stan is a digital transformation and information management technology professional with more than 20 years' experience across pharma and biotech.

INFORMATION GOVERNANCE CONSULTANT

Russell is a records management and information governance professional with extensive experience of selection, evaluation and implementation of archives and procedures, including metadata schema and digital preservation.

EARLY DRUG DEVELOPMENT SPECIALIST

Alasdair is a big pharma veteran, research director and chief scientific officer with 30 years’ experience in the application of scientific research to drug discovery and development with numerous positive proof of pre/clinical concepts across mechanisms in pain, neuroscience and inflammation to his name.

PHARMACOLOGIST

Neil is a research scientist with more than 20 years experience working in large pharmaceutical companies specialised in applied modelling and simulation, PKPD, and QSP.

CLINICAL PHARMACOLOGIST

Graham is a pharmacist and clinical pharmacologist of more than 30 years’ experience with extensive knowledge of translational science and significant track record of completing programs from candidate selection through FIH and PoC to submission and approval.

QUALITY ASSURANCE

Mark is a GCP clinical research professional with over 40 years’ experience in the pharmaceutical, sector. He has managed global system audits, conducted multiple onsite sponsor inspections, as well as held total responsibility for the delivery of GCP, GLP and Clinical Safety Quality Programmes in big pharma across five continents.

EVENTS MANAGER

Caroline brings substantial experience of working internationally in the production of small- and large-scale events to budget and with finesse, incorporating summits, incentive programmes, sales kick-off meetings, scientific advisory boards, and leadership events.

FINANCE AND OPERATIONS ANALYST

Armin is a charity trustee and trainee chartered governance professional. He co-headed an early career development initiative developed with the University of St Andrews and is a past fellow of the Royal Society of Arts.